Trial Profile
Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2012
Price :
$35
*
At a glance
- Drugs Adjuvanted Hepatitis-B vaccine (Recombinant)-Dynavax (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 03 Aug 2012 New trial record